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Polyubiquitination of the demethylase
Jhd2 controls histone methylation
and gene expression
Douglas P. Mersman, Hai-Ning Du, Ian M. Fingerman, Paul F. South, and Scott D. Briggs1
Department of Biochemistry, Purdue University, West Lafayette, Indiana 47907, USA; and the Purdue Cancer Center, Purdue
University, West Lafayette, Indiana 47907, USA

The identification of histone methyltransferases and demethylases has uncovered a dynamic methylation system
needed to modulate appropriate levels of gene expression. Gene expression levels of various histone demethylases,
such as the JARID1 family, show distinct patterns of embryonic and adult expression and respond to different
environmental cues, suggesting that histone demethylase protein levels must be tightly regulated for proper
development. In our study, we show that the protein level of the yeast histone H3 Lys 4 (H3 K4) demethylase Jhd2/
Kdm5 is modulated through polyubiquitination by the E3 ubiquitin ligase Not4 and turnover by the proteasome.
We determine that polyubiquitin-mediated degradation of Jhd2 controls in vivo H3 K4 trimethylation and gene
expression levels. Finally, we show that human NOT4 can polyubiquitinate human JARID1C/SMCX, a homolog
of Jhd2, suggesting that this is likely a conserved mechanism. We propose that Not4 is an E3 ubiquitin ligase that
monitors and controls a precise amount of Jhd2 protein so that the proper balance between histone demethylase
and histone methyltransferase activities occur in the cell, ensuring appropriate levels of H3 K4 trimethylation and
gene expression.
[Keywords: Jhd2; chromatin; histone methylation; demethylase; ubiquitination; proteasome]
Supplemental material is available at http://www.genesdev.org.
Received December 4, 2008; revised version accepted March 12, 2009.

The identification of both histone methyltransferases and
histone demethylases implies that a dynamic methylation system exists in eukaryotes. This dynamic methylation system is needed to modulate appropriate levels
of gene expression via histone lysine methylation and
methyl-binding factors. In Saccharomyces cerevisiae,
histone H3 K4, K36, and K79 methylation has been
associated with gene activation, and dynamic methylation changes have been detected for histone H3 K4 and
H3 K36 methylation (Ng et al. 2003; Ingvarsdottir et al.
2007; Klose et al. 2007; Liang et al. 2007; Seward et al.
2007; Tu et al. 2007).
Set1 is the sole SET domain-containing enzyme that is
necessary for catalyzing histone H3 K4 mono-, di-, and
trimethylation in S. cerevisiae (Briggs et al. 2001; Roguev
et al. 2001). It is required for silencing at the rDNA,
telomeres, and mating-type loci and has been purified as
a multiprotein complex (Nislow et al. 1997; Briggs et al.
2001; Miller et al. 2001; Roguev et al. 2001; Bryk et al.
2002; Fingerman et al. 2005). In addition, Set1 and H3 K4
trimethylation are enriched at the 59 ends of the open
1
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reading frames of transcriptionally active genes in both
yeast and higher eukaryotes (Santos-Rosa et al. 2002; Ng
et al. 2003; Schneider et al. 2004). These and other studies
suggest that Set1 and H3 K4 trimethylation play positive
roles in regulating gene expression (Dehe and Geli 2006).
The JmjC domain-containing protein Jhd2 was recently
purified from budding yeast as a monomeric subunit and
was shown to have in vitro histone H3 K4 demethylase
activity (Liang et al. 2007). Jhd2 was also shown to
remove H3 K4 di- and trimethylation in vivo after Set1
was depleted from the cells (Seward et al. 2007). However,
overexpressing Jhd2 in cells expressing Set1 showed only
slight but detectable decreases in H3 K4 trimethylation
(Liang et al. 2007). Deletion of Jhd2 has been shown to
have only a minor effect on GAL1 gene expression and
results in a less than twofold increase in H3 K4 trimethylation levels at the 59 end of the GAL1 gene
(Ingvarsdottir et al. 2007).
In addition to histone methyltransferases and demethylases, ubiquitin conjugating enzymes and ubiquitin
ligases are important for maintaining appropriate levels
of H3 K4 methylation. Rad6 and Bre1 are E2 ubiquitin
conjugating and E3 ubiquitin ligase enzymes, respectively, that have been shown to be necessary for H2B
K123 monoubiquitination (Robzyk et al. 2000; Hwang
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et al. 2003; Wood et al. 2003). Subsequently, H2B K123
monoubiquitination is needed to control histone H3 K4
and K79 di- and trimethylation by a trans-histone pathway (Briggs et al. 2002; Dover et al. 2002; Ng et al. 2002;
Sun and Allis 2002). It has been shown that the Rpt4 and
Rpt6/Cim3 ATPase subunits of the 26S proteasome are
recruited to chromatin by H2B ubiquitination and that
mutations in Rpt4 and Rpt6/Cim3 that prevent ATPase
function block H3 K4 and K79 methylation (Ezhkova and
Tansey 2004). These data suggest that Rpt4 and Rpt6
might functionally link H2B ubiquitination to histone H3
K4 and K79 methylation (Ezhkova and Tansey 2004). A
mutant of the Rpt1/Cim5 ATPase subunits of the 26S
proteasome also shows defects in H3 K4 trimethylation
(Laribee et al. 2007). However, the precise mechanism by
which the proteasome controls histone methylation
needs further investigation.
Not4 is another E3 ubiquitin ligase that has been
shown to be important for wild-type levels of H3 K4
trimethylation (Laribee et al. 2007; Mulder et al. 2007a).
Not4 is one of the subunits of the CCR4/NOT complex,
a multifunctional complex that has been implicated
in transcriptional regulation and RNA deadenylation
(Collart and Struhl 1994; Denis et al. 2001; Collart
2003; Collart and Timmers 2004; Mulder et al. 2007b).
Although the precise role played by Not4 in the CCR4/
NOT complex remains to be determined, Not4 has been
shown to have both positive and negative roles in
transcriptional regulation and a positive role in transcriptional elongation (Collart 2003). In addition, the RING
finger domain of yeast Not4 has been shown to be
important for the induction of the ribonucleotide reductase (RNR) gene family in response to DNA damage
via MMS and hydroxyurea and for E3 ubiquitin ligase
activity (Mulder et al. 2007b). Until now, the mechanism
by which Not4’s RING finger domain acts to modulate
histone H3 K4 methylation has been unclear and contradictory (Laribee et al. 2007; Mulder et al. 2007a).
These studies, as well as others, suggest that a proper
balance of chromatin-modifying enzymes is needed for
appropriate gene expression (Shi and Whetstine 2007; Lan
et al. 2008). If this balance is disrupted, aberrant gene
expression may lead to cell growth defects resulting in
abnormal development and cancer (Shi and Whetstine
2007; Wang et al. 2007). Therefore, understanding the
mechanism that regulates the balance between histone
methyltransferases and demethylases is important and
needs to be further explored.
In this study, we demonstrate that the protein level of
the histone H3 K4 demethylase Jhd2 and its associated
demethylase activity are controlled by Not4 through
a polyubiquitin-mediated degradation process. We show
that Jhd2 is polyubiquitinated in vitro and in vivo by
Not4 and degraded by the proteasome. In addition, in the
absence of Not4 or in the presence of a Not4 mutant that
lacks the RING finger domain, Jhd2 protein levels increase while histone H3 K4 trimethylation levels decrease. Importantly, we determine that gene expression
is modulated by the amount of Jhd2 present and by H3 K4
trimethylation levels. We also show that JARID1C, the
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human homolog of Jhd2, is ubiquitinated in vitro by
human Not4. Our study suggests that polyubiquitination
by E3 ubiquitin ligases and subsequent proteasomemediated degradation of histone demethylases is an
important control mechanism in eukaryotes used to
maintain a proper balance between histone methyltransferase and demethylase activities.
Results
High levels of Jhd2 protein expression are required
to detect in vivo H3 K4 demethylation
In S. cerevisiae, subtle but detectable changes in histone
H3 K4 methylation have been observed when Jhd2 is
overexpressed or deleted while in the presence of the H3
K4 methyltransferase Set1 (Liang et al. 2007). However,
significant changes in H3 K4 methylation are observed
only when Set1 is depleted in the presence of Jhd2 but not
in the absence of Jhd2 (Seward et al. 2007). To explore the
possibility that a proper balance of histone methyltransferases and demethylases is needed to detect significant
changes in histone methylation, we wanted to determine
if the amount of Jhd2 protein expressed affected in vivo
H3 K4 methylation (Fig. 1B; Liang et al. 2007). Therefore,
Flag epitope-tagged Jhd2 was expressed from CEN-based
plasmids under the control of its own promoter (JHD2p)
or overexpressed under the control of two constitutive
yeast promoters, ADH1 (ADH1p) and PYK1 (PYK1p), in
a yeast strain containing wild-type JHD2 and an endogenously MYC-tagged Set1. Jhd2 expression under the
control of its own promoter is not detectable in wholecell lysates when immunoblotted with a-Flag antibodies,
while low levels of Jhd2 are detectable when it is
expressed under the control of the ADH1 promoter (Fig.
1B, cf. lanes 3 and 4). Interestingly, Jhd2 expressed from
its own promoter or an ADH1 promoter did not lead to
a detectable decrease in histone H3 K4 trimethylation
levels (Fig. 1B). Expression of Jhd2 from the PYK1 promoter shows significantly increased amounts of protein
expression relative to Jhd2 expressed from its endogenous
promoter or an ADH1 promoter (Fig. 1B, cf. lanes 3–5).
In addition, the increased amount of Jhd2 expressed
from the PYK1 promoter was sufficient to result in a substantial decrease in H3 K4 trimethylation and subtle
decreases in H3 K4 dimethylation (Fig. 1B [lane 5], D
[lane 3]). This decrease in H3 K4 trimethylation was not
due to differences in histone H3 levels since immunoblots show equivalent levels of histone H3 (Fig. 1B).
Furthermore, the amount of Jhd2 protein in a cell did
not appear to alter the protein level of MYC-tagged Set1,
suggesting that the observed decrease in H3 K4 trimethylation was a result of Jhd2’s demethylase activity
(Fig. 1B).
Because Jhd2 expressed from its own promoter was not
detectable in whole-cell lysates, immunoprecipitation
assays were performed. Whole-cell lysates from strains
expressing Flag-tagged Jhd2 from the JHD2, ADH1, or
PYK1 promoters were normalized for protein levels, immunoprecipitated with a-Flag resin, and immunoblotted
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Figure 1. Histone H3 K4 trimethylation is modulated by Jhd2 protein levels. (A) Schematic of Jhd2
illustrating positions of the JmjN, PHD, and JmjC
domains. Numbers indicate amino acid positions.
(B) Immunoblots of whole-cell lysates using H3 K4
mono-, di-, and trimethyl antibodies show the H3
K4 methylation status from yeast strains expressing the indicated constructs. An immunoblot
probed with a-H3 antibodies serves as a loading
control. Flag-tagged Jhd2 and 3XMYC-Set1 proteins levels are assessed by immunoblots using aFlag or a-MYC (9E10) antibodies. (C) Flag-tagged
JHD2 driven by its own promoter (JHD2p), the
ADH1 promoter (ADH1p), or the PYK1 promoter
(PYK1p) was immunoprecipitated from whole-cell
lysates. Detection of Flag-tagged Jhd2 is determined by immunoblotting with an a-Flag antibody.
Histone H3 is used as a loading control. (D) Wholecell lysates generated from yeast strains expressing
the indicated constructs are immunoblotted with
H3 K4 mono-, di-, and trimethyl antibodies. As
controls, a-Flag and a-H3 antibodies are used to
determine Jhd2 and histone H3 proteins levels.

with a-Flag antibodies (Fig. 1C). After immunoprecipitation, Jhd2 expressed from its own promoter was detectable (Fig. 1C, lane 3). Immunoprecipitation of Jhd2 also
confirmed that Jhd2 expression is substantially higher
from a PYK1 promoter than from either its own promoter
or when driven by the ADH1 promoter (Fig. 1C). A
histone H3 immunoblot confirmed that the protein
lysates were normalized before immunoprecipitation
(Fig. 1C). Although it was previously shown that overexpression of Jhd2 results in decreases in H3 K4 trimethylation, our results suggest that there is a critical
amount of Jhd2 needed to offset the balance of histone
methylation in favor of demethylase activity.
To determine if the decrease in H3 K4 trimethylation
was a consequence of Jhd2 demethylase activity, we
generated a catalytically inactive mutant of Jhd2 (Jhd2
H427A) under the control of the PYK1 promoter (Liang
et al. 2007). While overexpression of wild-type Jhd2
resulted in decreased H3 K4 trimethylation, overexpression of Jhd2 H427A did not have a detectable effect on H3
K4 trimethylation (Fig. 1D, cf. lanes 3 and 4). These
results suggest that the loss of H3 K4 trimethylation
observed when Jhd2 is overexpressed is due to its demethylase activity. It has been reported that the PHD
domain of Jhd2 is not required for in vitro demethylase
activity (Ingvarsdottir et al. 2007). We find that overexpressing Jhd2 lacking its PHD domain (Jhd2 DPHD)
from a PYK1 promoter did not affect H3 K4 trimethylation (Fig. 1D, lane 5). This is similar to what is observed
when the catalytically inactive mutant Jhd2 H427A is
overexpressed (Fig. 1D, cf. lanes 4 and 5). This is not due
to differential expression of Jhd2, as near equal levels of
Jhd2, Jhd2 H427A, and Jhd2 DPHD were detected when
expressed in the jhd2D strain (Fig. 1D). Together, our in
vivo results show that the PHD domain of Jhd2, and
a particular amount of active Jhd2 protein, are needed to
overcome Set1-mediated methylation before an observ-

able loss of histone H3 K4 trimethylation is globally
detected. Our results suggest that a cell must monitor and
control a critical balance between Jhd2 and Set1 for
proper histone methylation. Therefore, Jhd2 is either
expressed at very low levels from its own promoter and/
or Jhd2 protein levels are post-transcriptionally controlled by a protein degradation mechanism.
The protein level of Jhd2 is controlled
by the proteasome
Since a particular amount of Jhd2 protein is needed to
detect loss of H3 K4 trimethylation, and Jhd2 is expressed
at very low levels, we wanted to determine if Jhd2 protein
levels were post-translationally regulated by a proteasomemediated degradation pathway. Since Jhd2 is not detectable from whole-cell lysates when expressed from its own
promoter, we wanted to determine if inhibiting the
proteasome with MG132 would increase the amount of
detectable Jhd2 protein when expressed from its own
promoter (JHD2p). To determine this, Flag-tagged Jhd2
was expressed from its own promoter in a strain lacking
both JHD2 and PDR5 (jhd2Dpdr5D). Yeast cells lacking
the multidrug transporter Pdr5 are more sensitive to
MG132 and are commonly used in combination with
proteasome inhibitors to assess protein turnover/degradation (Ravid and Hochstrasser 2007).
After 30 min of treatment with either DMSO or
MG132, whole-cell lysates were immunoblotted with
a-Flag antibodies to determine the amount of Jhd2
expressed. Similar to what was observed in Figure 1B,
Jhd2 was not detectable in cells expressing Jhd2 from its
own promoter when treated with DMSO (Fig. 2A, lanes
2,3). In contrast, when cells expressing Jhd2 were treated
with MG132, a dramatic increase in Jhd2 protein levels is
observed (Fig. 2A, lanes 5,6). Histone H3 levels were
monitored and used as a loading control. To confirm that
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Figure 2. The proteasome mediates degradation of Jhd2. (A) A
jhd2Dpdr5D yeast strain expressing JHD2-Flag driven by the
JHD2 promoter (JHD2p) was treated with either DMSO or
MG132. Immunoblots of whole-cell lysates are probed using
an a-Flag antibody to detect the amount of Jhd2 protein
expressed. Histone H3 is used as a loading control. (B) Transcript
levels of JHD2 under the control of its endogenous promoter
were examined after DMSO or MG132 treatment by quantitative real-time PCR.

the elevated levels of Jhd2 observed in Figure 2A are not
due to increased transcription of JHD2, we analyzed the
levels of Jhd2 transcript (mRNA) in cells treated with
either DMSO or MG132 by quantitative real-time PCR.
Our results indicate that Jhd2 transcript levels did not
increase in cells treated with MG132 relative to untreated cells, indicating that the observed increase in
Jhd2 protein levels is due to inhibition of the proteasome
and not increased transcription (Fig. 2B). Our results
strongly indicate that Jhd2 protein levels are tightly
controlled by the proteasome and are kept at a low level
so that proper H3 K4 trimethylation can take place.
Jhd2 is polyubiquitinated in vivo, and inhibition
of Jhd2 protein degradation decreases H3 K4
trimethylation levels
Post-translational modifications on histone demethylases have been suggested to modulate demethylase
activity (Lan et al. 2008). However, post-translational
modifications on yeast or mammalian histone demethylases that alter histone methylation levels have not been
identified. Based on our results showing that the proteasome can control Jhd2 protein levels, we predicted that
Jhd2 is post-translationally modified by ubiquitin in vivo
and is thus targeted for degradation. Therefore, ubiquitinmediated degradation of Jhd2 would be an ideal mechanism to tightly control the balance between histone
demethylase and histone methyltransferase activities in
the cell. To test this idea and to identify a potential
ubiquitination site on Jhd2, wild-type Flag-Jhd2, Flag-Jhd2
DPHD, and Flag-Jhd2 N- and C-terminal truncation
mutants were expressed from an ADH1 promoter in
a jhd2D strain (see Fig. 1A for positions of Jhd2 mutations
represented in Fig 3A). Whole-cell lysates derived from
the indicated strains were immunoprecipitated with
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a-Flag resin and immunoblotted for Flag-Jhd2 and ubiquitin using a-Flag and a-Ubiquitin (Ub) antibodies. We
clearly observe that Jhd2 is polyubiquitinated when
isolated from cells (Fig. 3A). Importantly, polyubiquitination was specific to Jhd2 since no polyubiquitination was
detected in a jhd2D strain expressing empty vector (Fig.
3A, lane 1). Interestingly, all of the Jhd2 mutants analyzed
also appear to be polyubiquitinated (Fig. 3A, lanes 3–8).
Further work will be needed to determine if one or more
ubiquitination sites are involved in degrading Jhd2. This
would not be unexpected, as it is known that E3 ubiquitin
ligases can ubiquitinate more than one lysine residue on
a substrate (Pickart 2001; Peng et al. 2003).
To confirm that polyubiquitination of Jhd2 was
not artificially caused by overexpression of Jhd2, Jhd2
under the control of its own promoter was expressed
in a jhd2Dpdr5D strain. In order to capture polyubiquitinated Jhd2 that is under the control of its own promoter,
cells expressing Jhd2-Flag were treated with or without MG132 for 30 min. Whole-cell lysates were prepared
in the presence of the thiol-alkylating agent Nethylmaleimide (NEM) in order to inhibit deubiquitination of Jhd2 upon cell lysis. Strikingly, robust levels of
polyubiquitinated Jhd2 are detected from cells expressing
Jhd2 from its own promoter when treated with both
MG132 and NEM (Fig. 3B). Since Jhd2 is highly polyubiquitinated after MG132 and NEM treatment, less
unmodified Jhd2 was able to be immunoprecipitated from
MG132- and NEM-treated cells than from cells treated
with only NEM (Fig. 3B, cf. lanes 3 and 4). In addition,
polyubiquitination of Jhd2 was specific since it was not
detected in wild-type or jhd2Dpdr5D cells expressing
empty vector. Furthermore, polyubiquitination of Jhd2
was not due to the Flag tag since Jhd2 tagged with HA was
also observed to be polyubiquitinated in a similarly
robust manner (data not shown).
To address the possibility that episomal expression of
Jhd2 expressed from its own promoter resulted in artificial polyubiquitination of Jhd2, a 3XFlag tag was engineered at the C terminus of Jhd2 at its endogenous locus.
To sensitize Pdr5-positive cells for better uptake of
MG132, wild-type and the integrated Jhd2-3XFlag strains
were treated as described previously (Liu et al. 2007).
Whole-cell lysates were prepared in the presence of NEM
to prevent deubiquitination of Jhd2. Robust levels of
polyubiquitinated Jhd2 were detected in cells expressing
Jhd2-3XFlag at its endogenous locus that were treated
with NEM and MG132 (Fig. 3C, lane 3). MG132 treatment was needed to detect polyubiquitinated Jhd2 (Fig.
3C, cf. lanes 2,3). Together, our results unequivocally
indicate that Jhd2 is polyubiquitinated under physiologically expressed conditions and when it is overexpressed.
Since inhibition of the proteasome by MG132 results in
higher levels of Jhd2 protein, we wanted to determine if
proteasome inhibition would affect global H3 K4 trimethylation levels in a Jhd2-dependent manner. To test this,
Jhd2 was deleted in a strain expressing MYC-tagged Set1
at its endogenous locus. To sensitize cells to MG132
treatment, wild-type and jhd2D strains were treated as
described previously (Liu et al. 2007). MG132 treatment of
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Figure 3. Jhd2 is polyubiquitinated in vivo. (A)
JHD2 and jhd2 mutant constructs were expressed
from an ADH1 promoter (ADH1p). Subscripted
numbers represent amino acid positions and protein size of Jhd2 mutants. Whole-cell extracts
expressing the indicated Jhd2 constructs were
immunoprecipitated with a-Flag resin. Detection
of Flag-Jhd2 and Flag-Jhd2 mutants are determined
by immunoblotting with an a-Flag antibody. Polyubiquitination of FLAG-Jhd2 is detected with an aUbiquitin antibody. Histone H3 immunoblots
shows equivalent amounts of lysates were used
for immunoprecipitation. (B) JHD2 driven by its
own promoter (JHD2p) was immunoprecipitated
from whole-cell lysates of strains expressing the
indicated constructs. Strains were treated with or
without MG132 before cell lysis, and whole-cell
lysates were prepared in an extraction buffer containing NEM before immunoprecipitation. Detection of Flag-Jhd2 is determined by immunoblotting
with a-Flag antibody. Polyubiquitinated Flag-Jhd2
is detected with a-Ubiquitin antibody. A histone
H3 immunoblot serves as a loading control. (C)
JHD2-3XFlag expressed from its endogenous locus
was treated with or without MG132 before immunoprecipitation. Whole-cell lysates were prepared in the presence of NEM to inhibit
deubiquitination. Detection of Jhd2-3XFlag is determined by immunoblotting with an a-Flag antibody. Polyubiquitinated Jhd3-3XFlag
is detected with an a-Ubiquitin antibody. A histone H3 immunoblot serves as a loading control, and untagged JHD2 serves as a control
for immunoprecipitation. (D) Wild-type and jhd2D yeast strains in which 3XMYC-Set1 was tagged at its endogenous locus were treated
with MG132 and samples were taken at the indicated time points. Immunoblots of whole-cell lysates are probed with a-H3 K4
trimethyl and a-H3 antibodies. 3XMYC-Set1 was detected by immunoprecipitation followed by immunoblotting with an a-MYC
antibody.

the wild-type strain resulted in substantially decreased
levels of H3 K4 trimethylation after 90 min (Fig. 3D,
lane 9). In a different strain, a similar decrease in H3 K4
trimethylation was obtained in a jhd2Dpdr5D strain
expressing Jhd2 (Supplemental Fig. S1). Importantly, the
observed reduction of H3 K4 trimethylation required the
presence of Jhd2, since inhibition of the proteasome by
MG132 in a jhd2D strain had no apparent effect on H3 K4
trimethylation (Fig. 3D, lanes 2–5). Changes in H3 K4
trimethylation were not due to decreased levels of Set1
expression or changes in histone H3 levels since immunoblots showed that MYC-tagged Set1 is similarly
expressed in both strains and showed nearly equivalent
loading (Fig. 3D). Together, our results show that Jhd2
expressed from its endogenous locus is controlled by
being post-translationally modified by ubiquitin and degraded by the proteasome. Inhibition of Jhd2 degradation
in turn leads to increased Jhd2 protein levels and decreased levels of H3 K4 trimethylation.
Jhd2 and Not4 genetically interact to mediate proper
levels of H3 K4 trimethylation
Since Jhd2 is ubiquitinated in vivo and degraded by the
proteasome, we wanted to identify the enzyme responsible for ubiquitinating Jhd2 using a genetic approach. We
predicted that Jhd2 would not be ubiquitinated in a yeast
strain that lacked this enzyme and that this strain would
have decreased levels of trimethylated H3 K4 because of
increased amounts of Jhd2 protein. Yeast strains that are

deleted for both JHD2 and the enzyme that ubiquitinates
Jhd2 would be expected to restore H3 K4 trimethylation.
Based on the above criteria, Rad6, an E2 ubiquitinconjugating enzyme that, when deleted, disrupts H3 K4
mono-, di-, and trimethylation, and Not4, an E3 RING
finger domain ubiquitin ligase that when deleted decreases global H3 K4 trimethylation, were chosen as the
most likely candidates to ubiquitinate Jhd2 (Sun and Allis
2002; Wood et al. 2003; Shahbazian et al. 2005; Laribee
et al. 2007).
The H3 K4 mono-, di-, and trimethylation levels in
a rad6D strain were similar to those in a rad6Djhd2D
strain as indicated by immunoblotting with methylspecific H3 K4 antibodies (Fig. 4A, lanes 4,5). The levels
of histone H3 and H3 K36 trimethylation were used as
controls (Fig. 4A). To show specificity of K4 and K36
methyl-specific antibodies, set1D and set2D strains were
used (Fig. 4A). This suggests that Rad6 does not modulate
Jhd2 protein levels by polyubiquitination. As previously
published, a not4D strain exhibited a decrease in H3 K4
trimethylation (Laribee et al. 2007; Mulder et al. 2007a).
However, as predicted based on a genetic interaction,
wild-type levels of H3 K4 trimethylation were restored in
a not4Djhd2D double deletion strain (Fig. 4B, lanes 4,5).
No changes in global levels of H3 K4 mono- or dimethylation were detected in jhd2D, not4D, or not4Djhd2D
strains, and histone H3 immunoblots indicated equal
loading (Fig. 4B). These results suggest that Not4 is the
E3 ubiquitin ligase controlling Jhd2 protein levels.
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Figure 4. Not4 and Jhd2 genetically interact and
modulate H3 K4 trimethylation. (A) Histone H3 K4
and K36 methylation levels were analyzed from
whole-cell lysates from the indicated strains by
immunoblotting using H3 K4 mono-, di-, and
trimethylation and H3 K36 trimethylation antibodies. Histone H3 is used as loading control. (B)
Histone H3 K4 methylation status of the indicated
strains was determined using the indicated H3 K4
methyl-specific and histone H3 antibodies. (C)
Whole-cell lysates from the indicated yeast deletion strains are analyzed for H3 K4 methylation.
Histone H3 levels and expression of Jhd2-Flag and
Jhd2-Flag mutants are verified by a-H3 and a-Flag
antibody immunoblots.

To show that the restoration of H3 K4 trimethylation in
the not4D jhd2D strain was the result of losing the
demethylase activity of Jhd2 and to confirm the importance of the PHD domain for Jhd2 demethylase activity,
wild-type Jhd2, Jhd2 H427A, and Jhd2 DPHD were
expressed under the control of the JHD2 promoter
(JHD2p) in the not4D jhd2D strain. Expression of wildtype Jhd2 in the not4D jhd2D strain resulted in decreased
levels of H3 K4 trimethylation similar to what is observed in a not4D strain (Fig. 4C, lanes 4,6). As expected,
expression of either Jhd2 H427A or Jhd2 DPHD did not
result in a detectable decrease H3 K4 trimethylation (Fig.
4C, lanes 7,8). Changes in H3 K4 trimethylation levels are
specific to the protein level and demethylase activity of
Jhd2 since equal loading of histone H3 is shown by H3
immunoblots. Unlike in cells expressing Not4, Jhd2
expressed from its own promoter is detected in wholecell lysates in the absence of Not4 (cf. Figs. 1B [lane 3] and
4C [lane 6]). Jhd2 H427A and Jhd2 DPHD are also detected
in the absence of Not4 (Fig. 4C, lanes 7,8). Using these
genetic approaches, we showed that Jhd2 and Not4 are
both necessary to mediate proper levels of H3 K4 trimethylation. More importantly, our data suggest that the
histone demethylase Jhd2 is a potential in vivo substrate
for Not4-mediated polyubiquitination.

Not4’s own promoter (NOT4p) in a not4D strain. While
expression of Not4 and Not4 DRRM in a not4D strain
resulted in restoration of wild-type levels of H3 K4
trimethylation, expression of either empty vector or
Not4 DRING did not restore H3 K4 trimethylation (Fig.
5B, cf. lanes 3,5 and 4,6). Immunoblots using a-HA and
a-H3 antibodies indicated that all Not4 constructs were
equivalently expressed and equally loaded (Fig. 5B). To
determine if the RING finger domain of Not4 was

The RING finger domain of Not4 mediates in vivo H3
K4 trimethylation and Jhd2 protein levels
It has recently been determined that Ubc4 is the E2
ubiquitin conjugating enzyme for Not4 and that the
RING finger domain of Not4 is needed to mediate
ubiquitination of itself and one identified substrate
(Albert et al. 2002; Panasenko et al. 2006; Mulder et al.
2007a). In addition, an N-terminal truncation of Not4
that removes the RING finger domain cannot restore H3
K4 trimethylation in a not4D strain (Laribee et al. 2007).
To determine if the RING finger domain of Not4 by itself
is important for proper levels of H3 K4 trimethylation, we
constructed Not4 deletion mutants lacking either the
RING finger domain or the putative RNA recognition
motif (RRM) (Fig. 5A). Wild-type Not4 and both Not4
deletion mutants were HA-tagged and expressed from
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Figure 5. The RING finger domain of Not4 is required for H3
K4 trimethylation and Jhd2 protein stability. (A) Schematic of
Not4 illustrating positions of RING and RRM domains. Numbers indicate amino acid positions. (B) Whole-cell lysates from
yeast strains expressing the indicated constructs were analyzed
for histone H3 K4 methylation by immunoblotting with H3 K4
mono-, di-, or trimethyl-specific antibodies. Histone H3 levels
and expression levels of Not4-HA and Not4-HA deletion
mutants were verified using a-H3 and a-HA antibodies. (C)
Jhd2 expression was analyzed in a not4Djhd2D strain expressing
the indicated Not4 constructs with a a-Flag antibody. HA-tagged
Not4 and Not4 deletion mutants are detected with a a-HA
antibody. Histone H3 is used as a loading control.
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important for maintaining wild-type levels of Jhd2 protein, Jhd2 was coexpressed with wild-type Not4, Not4
DRING, or Not4 DRRM. All constructs were expressed
from their own promoters in a not4D jhd2D strain.
Coexpression of Jhd2 with Not4 DRING resulted in
a significant increase of Jhd2 protein levels relative to
when Jhd2 was expressed with wild-type Not4 or Not4
DRRM (Fig. 5C, cf. lanes 7–9). Wild-type Jhd2 and the
indicated Not4 constructs were expressed individually as
controls (Fig. 5C, lanes 3–6). Together, our results identify
Jhd2 as a potential substrate for Not4 and indicate that the
RING finger domain of Not4 mediates both H3
K4 trimethylation and Jhd2 protein levels. This suggests
that Jhd2 may be a novel substrate for Not4-mediated
polyubiquitination.
Yeast and human Not4 ubiquitinate yeast and human
histone demethylases, Jhd2 and JARID1C
Since we determined that Jhd2 can be ubiquitinated in
vivo and that the RING domain of Not4 is required to
control Jhd2 protein and H3 K4 trimethylation levels,
we predicted that Not4 would polyubiquitinate Jhd2 in
vivo and in vitro. To test this, yeast Not4 and Jhd2 were
expressed in Escherichia coli and purified for use in an
in vitro ubiquitination assay. In the presence of purified
ubiquitin-activating enzyme Ube1 (E1) and ubiquitinconjugating enzyme Ubc4 (E2), Not4 (E3) is able to
mediate polyubiquitination of CBP-tagged Jhd2 in 30
min as indicated by the accumulation of high molecular
weight species detected in a-CBP immunoblots (Fig. 6A).
Polyubiquitination of Jhd2 did not occur when Ube1,
Ubc4, or Not4 were excluded from the ubiquitination
reaction. As an additional control, inclusion of the
alkylating agent NEM, which inhibits the activity of E2
ubiquitin-conjugating enzymes, in the reaction also prevented polyubiquitination of Jhd2 (Fig. 6A). As a control

for nonspecific ubiquitination by Not4, CBP-tagged Bre2,
a component of the yeast Set1 complex, was included in
a similar in vitro ubiquitination assay (Supplemental Fig.
S2A,B). Not4 does not polyubiquitinate Bre2 under similar conditions used for detecting polyubiquitinated Jhd2,
suggesting that Jhd2 is a bona fide substrate of Not4
(Supplemental Fig. S2A,B).
To test if Jhd2 is a relevant substrate for Not4-mediated
ubiquitination in vivo, wild-type and not4D strains
expressing Jhd2-3XFlag from its endogenous locus were
sensitized to MG132 treatment as described (Liu et al.
2007). After 30 min incubation with or without MG132,
whole-cell lysates were prepared in the presence of NEM
to prevent artificial deubiquitination of Jhd2. Immunoprecipitation of whole lysates with a-Flag resin and
immunoblotting with a-Flag and a-Ubiquitin antibodies
were used to detect unmodified Jhd2 and polyubiquitinated Jhd2. Polyubiquitination of Jhd2 was detected in
the presence of Not4; however, in the absence of Not4,
polyubiquitination of Jhd2 was eliminated (Fig. 6B, cf.
lanes 3 and 4). In addition, Flag-tagged Jhd2 was polyubiquitinated when expressed from the ADH1 promoter
in jhd2D, but polyubiquitination of Jhd2 was greatly
decreased when expressed in a not4D jhd2D strain (Supplemental Fig. S3, cf. lanes 4,5). Our in vitro and in vivo
biochemical studies show that Jhd2 is a novel substrate
for the E3 ligase activity of Not4 and is the second
identified substrate for Not4. Furthermore, Not4 is
needed to control the levels of Jhd2 to maintain appropriate levels of H3 K4 trimethylation in vivo.
Because Jhd2 and Not4 are conserved in humans, we
wanted to determine if JARID1C, the human homolog of
yeast Jhd2, would be subject to ubiquitination by human
Not4 (Hanzawa et al. 2001). To test this, bacterial constructs that express the first 700 amino acids (1–700
amino acids) of JARID1C or human Not4 were generated
and expressed in E. coli and purified for use in an in vitro

Figure 6. Jhd2 is polyubiquitinated by the E3 ubiquitin ligase Not4 in vitro and in vivo. (A) In vitro
ubiquitination assays were performed by incubating
Jhd2 and Not4 with Ube1, Ubc4, ATP, and free ubiquitin for 0, 30, 60, and 90 min. Polyubiquitinated and
unmodified CBP-tagged Jhd2 were detected with a aCBP antibody. NEM is used as a control to show
specificity by inhibiting the ubiquitination reaction.
(B) JHD2-3XFlag expressed from its endogenous locus
was treated with or without MG132 and immunoprecipitated from the indicated strains. Polyubiquitination
and expression of Jhd2 were confirmed with aUbiquitin and a-Flag antibodies. Immunoblots of histone H3 from whole-cell lysates indicated equivalent
amounts of lysates used for immunoprecipitation assays. NEM was added to the lysis buffer to inhibit deubiquitination. (C) In vitro ubiquitination assays were
performed by incubating JARID1C1–700 and hNot4
(human E3) with Ube1and UbcH5a in the presence of
ATP and ubiquitin. Polyubiquitinated and unmodified
JARID1C1–700 were detected by immunoblotting with
an a-CBP antibody. NEM was used as a control to show
specificity and inhibit the ubiquitination reaction.
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ubiquitination assay. In the presence of Ube1 (E1) and
UbcH5a (E2 and the human homolog of Ubc4), human
Not4 was able to polyubiquitinate JARID1C (Fig. 6C).
Polyubiquitinated JARID1C was not detected when the
E2 conjugating enzyme was inhibited by NEM or when
Ube1, UbcH5a, or hNot4 were missing from the ubiquitination reaction (Fig. 6C). These in vitro results demonstrate that human demethylases are capable of being
ubiquitinated and suggest that human Not4 or other E3
ubiquitin ligases may be important in regulating human
histone demethylases and histone methylation levels in
a manner similar to what we showed in yeast.
Not4 and Jhd2 modulate GUA1 expression
and gene-specific H3 K4 trimethylation
Since we established that polyubiquitin-mediated degradation of Jhd2 by Not4 modulates in vivo H3 K4 trimethylation, we wanted to determine if gene expression
levels would also be modulated by Jhd2 and H3 K4
trimethylation levels. To test this idea, we examined
the gene expression of GUA1, a GMP synthetase, which
was recently determined by microarray analysis to be
a gene putatively regulated by Not4 (Cui et al. 2008). The
level of GUA1 expression was first analyzed in wild-type,
jhd2D, not4D, and not4Djhd2D strains expressing either
empty vector, Not4-HA, Jhd2-Flag, or jhd2 H427A-Flag
expressed from their own promoters by quantitative realtime PCR analysis (Fig. 7A; see Supplemental Table S3 for
quantitative values; see Supplemental Fig. S4A for primer

positions). GUA1 expression was decreased 2.5-fold in
a not4D strain compared with wild-type, but was restored
to wild-type levels in a not4D jhd2D strain (Fig. 7A; Supplemental Table S3). No significant change in GUA1
expression was observed between wild-type and jhd2D
strains (Fig. 7A; Supplemental Table S3). When Jhd2-Flag
was expressed in the not4D jhd2D strain, GUA1 expression was decreased 2.13-fold, similar to what is observed
in not4D (Fig. 7A; Supplemental Table S3). No significant
change in GUA1 expression was observed between a
wild-type strain, jhd2D, and a not4D jhd2D strain expressing either Not4-HA or the catalytically inactive jhd2
H427A-Flag (Fig. 7A; Supplemental Table S3). Similar
gene expression results were obtained from strains grown
in rich media (Supplemental Fig. S4B). In addition, GUA1
expression was analyzed by quantitative real-time PCR in
wild-type and set1D strains (Fig. 7B). GUA1 expression
was decreased 2.04-fold in the set1D strain relative to the
wild-type strain (Fig. 7B; Supplemental Table S4). For all
gene expression analysis, ACT1 (actin) mRNA was used
as an internal control. Taken together, these results suggest that Set1-mediated H3 K4 trimethylation is important for wild-type levels of GUA1 expression.
To determine if H3 K4 trimethylation at the GUA1
locus is affected in each of these strains, chromatin
immunoprecipitations (ChIPs) were performed using
H3 K4 di- and trimethyl antibodies. ChIP eluates were
analyzed by quantitative real-time PCR using TaqMan
primer and probe pairs designed to analyze the 59 and 39
ends of GUA1 and normalized to histone H3 levels (see

Figure 7. H3 K4 trimethylation is important
for wild-type expression of GUA1. (A,B) Expression of GUA1 was determined in the
indicated strains by quantitative real-time
PCR analysis. ACT1 (Actin) expression was
used as an internal control to normalize
expression levels. Data in A were analyzed
from six biological repeats with four technical
repeats each. Data in B were analyzed from
three biological repeats with three technical
repeats each. (C,D) ChIP from the indicated
strains were performed using antibodies specific to H3 K4 dimethylation, trimethylation,
and histone H3. ChIP eluates were analyzed
by quantitative real-time PCR using 59 and 39
GUA1 gene-specific TaqMan primer sets and
normalized to histone H3 levels. Data in C
and D were analyzed from three biological
repeats with three technical repeats each. See
Supplemental Tables S3–S6 for quantitative
values of gene expression and ChIP analysis.
(E) In the depicted model, the histone demethylase Jhd2 is polyubiquitinated by Not4 and
Ubc4. Upon polyubiquitination, Jhd2 is targeted for proteasome-mediated degradation
that permits the Set1 H3 K4 methyltransferase complex (Set1C) to maintain wild-type
levels of histone methylation resulting in normal levels of gene transcription. In the absence of Not4, Jhd2 ubiquitination and
subsequent degradation by the proteasome is greatly decreased. This leads to an increase in Jhd2 protein levels and its associated
demethylase activity, which offsets the methyltransferase activity mediated by Set1C resulting in decreased H3 K4 trimethylation and
gene expression.
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Supplemental Tables S5, S6 for quantitative values; see
Supplemental Fig S4A for primer positions). As expected,
GUA1 exhibits high levels of H3 K4 trimethylation at the
59 end and decreased levels of H3 K4 trimethylation at the
39 end in all strains (Fig. 7C; Supplemental Table S5;
Supplemental Fig. S5A,B). However, H3 K4 trimethylation is decreased 2.5-fold in the not4D strain at the 59 end
of GUA1 and is almost restored in the not4D jhd2D strain
when compared with wild-type cells (Fig. 7C; Supplemental Table S5; Supplemental Fig. S5A). In a similar
manner, H3 K4 trimethylation is decreased 4.5-fold in the
not4D strain at the 39 end of GUA1 and is partially
restored in the not4D jhd2D strain (Fig. 7C; Supplemental
Table S5; Supplemental Fig. S5B). Interestingly, we
observe that H3 K4 dimethylation is increased 3.2-fold
in the not4D strain at the 59 end of GUA1 and that
dimethylation is restored to wild-type levels in the not4D
jhd2D strain (Fig. 7D; Supplemental Table S6; Supplemental Fig. S5C). The increase in 59 H3 K4 dimethylation
in a not4D strain is likely due to the consequence of
decreased 59 H3 K4 trimethylation levels. In contrast, 59
H3 K4 dimethylation levels in a not4D jhd2D strain does
not change since 59 H3 K4 trimethylation levels are
nearly restore wild-type levels. Intriguingly, H3 K4 dimethylation levels at the 39 end of GUA1 decrease in a not4D
strain but do not appear to be restored in a not4Djhd2D
strain (Fig. 7D; Supplemental Table S6; Supplemental Fig.
S5D). H3 K4 dimethylation in a jhd2D strain appears to
have little, if any, effect on H3 K4 dimethylation at the
59 or 39 ends of GUA1 (Fig. 7D; Supplemental Table S6;
Supplemental Fig. S5C, D). Similar ChIP results were
obtained by PCR and gel analysis (Supplemental Fig.
S4C).
Together, these results show that GUA1 gene expression is modulated by the levels of H3 K4 trimethylation
mediated by Not4 and Jhd2. Overall, our results indicate
that polyubiquitination of Jhd2 by Not4 is a way to
control Jhd2 protein levels and its associated demethylase
activity so that appropriate levels of H3 K4 methylation
and gene expression occur in a cell (Fig. 7E).
Discussion
In this study, we determined for the first time that a
histone demethylase is polyubiquitinated in vivo, which
leads to degradation by the proteasome (Fig. 7E). More
importantly, we show that polyubiquitin-mediated degradation of Jhd2 is necessary to keep the levels of Jhd2
protein expression low so that its demethylase activity
does not disrupt global and gene-specific histone H3 K4
trimethylation and gene expression levels. We also identified Not4 as a RING finger domain E3 ubiquitin ligase
that mediates Jhd2 polyubiquitination in vivo and in
vitro. Furthermore, in the absence of Not4 or during
inhibition of the proteasome, Jhd2 protein levels are
significantly increased resulting in decreased H3 K4
trimethylation. Therefore, a critical role for Not4 and
the proteasome is to constantly monitor and maintain
low Jhd2 protein levels so that aberrant histone demethylation and gene expression do not take place. Finally,

we show that human Not4 can polyubiquitinate
JARID1C, a human homolog of Jhd2. Therefore, other
yeast and human E3 ubiquitin ligases are likely playing
key roles in maintaining the proper balance between
demethylase and histone methyltransferase activities.
Regulating and controlling histone
demethylase activity
Histone demethylases are expressed in a temporal and
tissue-specific manner in multicellular organisms, and
their expression patterns can be altered by various environmental cues (Lan et al. 2008). In addition, histone
demethylase activity can be regulated by associated
proteins (Shi et al. 2005). If histone demethylases are
aberrantly expressed or regulated, this can result in
devastating consequences such as human cancers or
developmental defects leading to mental retardation
(Shi and Whetstine 2007; Wang et al. 2007; Cloos et al.
2008). Therefore, how histone demethylases are regulated
at the gene or protein level needs further investigation and is essential for understanding their biological
function.
Interestingly, mammalian histone demethylases have
been shown to be post-translationally modified by phosphorylation (Lan et al. 2008). However, no biological
relevance has been attributed to a phosphorylated histone
demethylase and, until now, no other post-translational
modifications have been reported to occur on these
enzymes. Therefore, our results show for the first time
that both yeast Jhd2 and human JARID1C histone H3 K4
demethylases can be post-translationally modified by
ubiquitin in vitro. More importantly, we show that this
modification is physiologically relevant and functionally
important for maintaining proper histone methylation
and gene expression levels.
Recently, it has been shown that LSD1, a non-JmjC
domain histone demethylase, needs to associate with
CoREST, a known transcriptional corepressor complex,
in order to demethylate nucleosomal substrates and to
prevent LSD1 degradation by the proteasome (Shi et al.
2005). However, this study did not assess if inhibition of
the proteasome could affect LSD1’s activity or determine
if LSD1’s protein level was regulated by the proteasome in
an ubiquitin-dependent or -independent manner. Given
our results showing that Jhd2 protein level and demethylase activity is controlled by the proteasome in an
ubiquitin-dependent manner, it is likely that LSD1 and
other mammalian histone demethylases are regulated in
a similar manner.
Interestingly, the human homolog of Jhd2, JARID1D,
can directly associate with Ring6a/MBLR, a putative
RING finger domain-containing ubiquitin ligase
(Lee et al. 2007). This direct association was shown to
moderately regulate JARID1D demethylase activity in
vitro independent of any E1 and E2 activities (Lee et al.
2007). Intriguingly, this study did not determine if
Ring6a could ubiquitinate itself, JARID1D, or any other
substrates; thus, the substrates for Ring6a are currently
unknown. Future studies will be needed to determine
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if human Ring6a or other E3 ubiquitin ligases regulate histone demethylase activity by ubiquitination
and to determine if this is a conserved and widely used
mechanism.

roles, one for cellular localization and the other for
controlling protein levels.

The role of ubiquitin-mediating enzymes and the
proteasome in controlling histone methylation

Although a dynamic balance between histone demethylase and methyltransferase activities must exist for
proper histone methylation and gene expression, how
this balance is maintained and controlled has not been
explored. In our study, we identify a new mechanism that
utilizes the E3 ubiquitin ligase activity of Not4 to
monitor and control the balance between histone demethylase and methyltransferase activity (Fig. 7E). Because
of this control mechanism, Jhd2 levels are kept at
extremely low levels, likely explaining why deletion of
Jhd2 does not result in a detectable global increase in H3
K4 trimethylation or gene expression. Therefore, under
normal cellular growth conditions, the balance favors
maximal H3 K4 trimethylation at constitutively active
genes until monitoring by Not4 is removed.
Interestingly, when yeast are grown in galactosecontaining media, an increase in H3 K4 trimethylation
and gene expression is observed in a jhd2D strain at the
inducible GAL1 gene (Ingvarsdottir et al. 2007). In addition, Jhd2 is needed to decrease H3 K4 trimethylation
levels during the repression of GAL1 (Ingvarsdottir et al.
2007). Therefore, Not4 may also be regulated by environmental cues so that histone methylation can be dynamically altered at inducible and/or constitutive genes. It
will be interesting to determine if this is the case and if
controlling histone methylation by E3 ubiquitin ligases
is a widely conserved mechanism in yeast and higher
eukaryotes.

Several groups have shown that E2 ubiquitin conjugating
enzyme Rad6 and its E3 ubiquitin ligase Bre1 mediate in
vivo histone H3 K4 and K79 di- and trimethylation via
a trans-histone pathway (Latham and Dent 2007; Fingerman et al. 2008). Recently, two independent groups have
determined that the E3 ubiquitin ligase Not4 is important for mediating wild-type levels of H3 K4 trimethylation but not H3 K79 methylation (Laribee et al. 2007;
Mulder et al. 2007a). While all groups show that Not4
impacts histone H3 K4 trimethylation, the mechanisms
by which Not4 influences histone H3 K4 trimethylation
are contradictory (Laribee et al. 2007; Mulder et al. 2007a).
For example, it has been reported that a not4D strain has
decreased H2B ubiquitination, resulting in reduced PAF
transcriptional elongation complex at open reading
frames (Mulder et al. 2007a). In contrast, it has also been
reported that a not4D strain has increased levels of H2B
ubiquitination and does not affect recruitment of the PAF
elongation complex to genes (Laribee et al. 2007). Although this latter group did not determine the mechanism by which Not4 mediates H3 K4 trimethylation,
they did show that the 26S proteasome ATPase subunits
Cim3 and Cim5 are important in mediating H3 K4
trimethylation (Laribee et al. 2007). It is unclear how to
reconcile these contradictory findings. However, our
study strongly indicates that the E3 ubiquitin ligase
activity of Not4 mediates H3 K4 trimethylation by
a polyubiquitin-mediated degradation mechanism that
is needed to control the amount of Jhd2 protein and its
associated demethylase activity. In addition, our results
implicating the proteasome in controlling Jhd2 protein
and H3 K4 trimethylation levels could explain why
strains expressing temperature-sensitive proteasome
ATPase mutants exhibit decreased levels of H3 K4
trimethylation (Ezhkova and Tansey 2004; Laribee et al.
2007).
Until now, Egd2, a protein subunit found in the
nascent-associated polypeptide (NAC–EGD) complex,
has been the only known substrate for Not4-mediated
ubiquitination (Panasenko et al. 2006). In this study,
ubiquitination of the NAC–EGD complex, consisting of
Egd1 and Egd2, was reduced in a not4D strain, and in vitro
ubiquitination assays showed that Not4 together with
Ubc4 is capable of monoubiquitinating Egd2 in the
presence of Egd1. Interestingly, in the absence of Not4,
the NAC–EGD complex was mislocalized, but the protein stability of Egd1 or Egd2 was not affected (Panasenko
et al. 2006). In contrast, our study has identified Jhd2 as
a novel substrate of Not4 that can be polyubiquitinated
by Not4 both in vitro and in vivo and that Jhd2 polyubiquitination leads to protein degradation. Therefore,
Not4-mediated ubiquitination may have two distinct
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Materials and methods
Yeast strains and plasmids
See Supplemental Tables S1 and S2 and the Supplemental
Material for details on plasmids and yeast strains.
Yeast extraction and Western blotting analysis
Yeast extraction and Western blot analysis to detect modified
histones was performed as described previously (Briggs et al.
2001; Fingerman et al. 2005). See the Supplemental Material for
histone antibodies used. To detect Flag-tagged Jhd2, lysates were
run on 8% SDS-PAGE gels, transferred to PVDF, and immunoblotted with a-Flag (Sigma, F7425) used at a 1:5000 dilution. To
detect HA-tagged Not4, lysates were run on 8% SDS-PAGE gels,
transferred to PVDF, and immunoblotted with a-HA.11 (Covance, MMS-101R) used at a 1:5000 dilution. See the Supplemental
Material for details on immunoprecipitation of Jhd2 and Set1
from whole-cell extracts.
In vitro ubiquitination assay
One microgram of purified CBP-Jhd2 (yeast) or CBP-JARID1C1–700
was incubated with 0.5 mg of HIS-Not4 (yeast E3) or HIS-hNot4
(human E3), 0.25 mg of HIS-Ubc4 (yeast E2) (see the Supplemental Material for expression and purification) or UbcH5a
(human E2) (Boston Biochem), 0.125 mg of human Ube1 (E1)
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(Boston Biochem), and 0.75 mg of bovine ubiquitin (Sigma) in
a reaction mix containing 50 mM Tris (pH 7.5), 50 mM KCl,
2.5 mM MgCl2, 0.5 mM EDTA, 2.5 mM DTT, and 10 mM
ATP for various times at 30°C as indicated. To inhibit the
formation of polyubiquitin chains, 2 mM NEM was added
(Panasenko et al. 2006). Samples were separated by SDS-PAGE,
transferred to PVDF membrane, and immunoblotted with an
a-CBP antibody (Millipore, 06-297)
Protein analysis and proteasome inhibition
Ten-milliliter cultures of cells expressing Flag-tagged Jhd2 in
a Djhd2Dpdr5 strain were treated with DMSO or 0.1 mM MG132
for 30 min. Whole-cell lysates were prepared as described previously (Briggs et al. 2001; Fingerman et al. 2005). Jhd2-Flag and
histone H3 were detected using an a-Flag antibody and an a-H3
antibody. To sensitize yeast to MG132 in a Pdr5-positive strain,
yeast were treated as described previously (Liu et al. 2007).
Gene expression analysis
All quantitative real-time PCR reactions were performed using
a StepOne Real-Time PCR System (Applied Biosystems). See the
Supplemental Material for details and primer sequences.
ChIP
ChIPs were performed as described previously using H3 K4 diand trimethyl (Millipore) and histone H3 antibodies (Abcam)
(Kuo and Allis 1999). Immunoprecipitated DNA from three
biological repeats with three technical repeats each was analyzed
by quantitative real-time PCR using the TaqMan approach. See
the Supplemental Material for details and primer sequences.
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